Items Tagged ‘#pharmacogenomics testing’
June 21, 2018
Taking action: using pharmacogenomics testing to individualize care for colorectal cancer
By Sharon Rosen 
Every day, Pashtoon Kasi, M.D., M.B.B.S. is inspired by his patients with colorectal cancer to deliver the best, individualized care to meet their unique needs. As an oncologist at Mayo Clinic’s campus in Florida, Dr. Kasi is seeing many of the growing number of younger patients – those in their 20’s, 30’s and 40’s – diagnosed with […]
Tags: #CIMCon18, #clinical research, #drug-gene interactions, #Individualizing Medicine 2018, #medication side effects, #pharmacogenomics testing, #pre-emptive pharmacogenomics testing, center for individualized medicine, chemotherapy, colorectal cancer, Genetic Testing, mayo clinic
November 28, 2017
From pharmacogenomics to pharmaco-omics – individualized care for every patient
By Sharon Rosen
When prescribing a medication for you, your physician considers many factors, including your age, sex, weight and current health conditions. Now, add to that list your unique genetic characteristics. Your genes affect the way you respond to medications. Pharmacogenomics is a term used to describe the use of genomic information to help select the right […]
Tags: #drug-gene interactions, #pharmacogenomics testing, #RIGHT 10K study, center for individualized medicine, Dr. Liewei Wang, Dr. Richard Weinshilboum, individualized medicine, mayo clinic, Mayo Clinic Proceedings, pharmacogenomics
October 11, 2017
#CIMCon17 – precision medicine for smoking cessation, rare diseases and cancer screening
By Sharon Rosen
Ever wonder why some people can quit smoking while others try repeatedly without success? The answer may be related to your genetic makeup. Studies have shown that 70 percent of smokers want to quit, but only three percent are successful each year. That’s according to Rachel Tyndale, Ph.D., professor of Pharmacology and Psychiatry, Centre for […]
Tags: #cell-free DNA testing, #Dr. Minetta Liu, #Dr. Muhammed Murtaza, #Dr. Rachel Tyndale, #Dr. Richard Williams, #Dr. William Gahl, #liquid biopsies, #pharmacogenomics testing, #rare diseases, #rare genetic disorders, #smoking cessation, #Undiagnosed Disease Network
October 10, 2017
#CIMCon17 day two explores how precision medicine can improve population health
By Sharon Rosen
Sharing cutting-edge research, clinical practice insights and networking continued at the second day of Individualizing Medicine 2017: Advancing Care Through Genomics, a conference hosted by the Mayo Clinic Center for Individualized Medicine in Rochester, Minnesota. Empirical data critical to advancing genomic medicine Robert Green, M.D., started the morning sessions by acknowledging that there are still many who […]
Tags: #CIMCon17, #direct-to-consumer genetic testing, #Dr. Rachel Tyndale, #Dr. Robert Green, #Empirical genomic data, #Genomic data, #genomic testing, #Home DNA tests, #Individualizing Medicine 2017, #medical resarch, #pharmacogenomics testing, #smoking cessation
September 14, 2017
Q and A: How has genomics led to precision cancer care?
By Sharon Rosen
How has cancer care changed with advances in genomic medicine? For example, for patients diagnosed with melanoma today, will their treatment options be different than those that were available 10 or 15 years ago? These are some of the questions we posed to Aleksandar Sekulic, M.D., Ph.D., associate director, Mayo Clinic Center for Individualized Medicine, […]
Tags: #cancer treatment, #Genomic analysis, #pharmacogenomics testing, #targeted therapies, cancer, center for individualized medicine, Dr. Aleksandar Sekulic, Genetic Testing, genomics, mayo clinic, medical research, Melanoma
August 15, 2017
A lifesaving discovery – what one physician learned from his genetic test results
By Sharon Rosen
When Michael Stephens, M.D. joined other researchers in Mayo Clinic Center for Individualized Medicine in having their genomes sequenced, he expected to learn a few minor facts. But, what he found was a major health issue that had been hidden in his genes. Test results revealed Dr. Stephens had a genetic variant that increases his risk […]
Tags: #CIMCon17, #Dr. Michael Stephens, #genetic disorders, #malignant hyperthermia, #pharmacogenomics testing, center for individualized medicine, Genetic Testing, genomics, mayo clinic, medical research, PGx, pharmacogenomics
June 1, 2017
Mapping your DNA: Mayo patient shares her experience
By Sharon Rosen
Sandy Pobanz knows Mayo Clinic’s campus in Arizona very well. She volunteers with the Mayo Clinic Caring Canines Therapy Dog Program with her English golden retrievers, Benji and Teddy. They provide a special brand of comfort to patients in the Outpatient Radiation Oncology waiting area on Mayo Clinic’s Arizona campus in Scottsdale and Mayo Clinic […]
Tags: #benefactor, #CIMCon17, #disease risk, #DNA sequencing tests, #drug-gene reactions, #pharmacogenomics testing, #Sandy Pobanz, #Warfarin, center for individualized medicine, DNA, Genetic Counseling, Genetic Counselor